Invited Speakers

Dr Ashish Kr Agravatt is currently working as Associate Professor at PDU Govt. Medical College, Rajkot, Gujarat India.

He is a member in IFCC committee on public relation ; the corresponding member to the “IFCC committee on standardization of Thyroid Function Tests (C-STFT). He is also editorial board member of e journal of IFCC

He was awarded IFCC Roche Travel Scholarship and invited speaker to IFCC virtual global conference on critical role of laboratories in COVID 19 pandemic ,2021. Dr Ashish has tremendous interest in quality improvement and development of Laboratory Information system. Besides delivering the responsibility as a Biochemist , he has created YouTube channels and websites on Biochemistry . You can visit his youtube channel “livebiochemistry” & website: www.livebiochemistry.com.

Dr Animesh Bardoloi, MBBS, MD (Biochemistry) has 17 years of experience in Clinical Biochemistry and is currently heading Alcare Diagnostics as the Group Quality Head. With Quality as passion, he is a 6 sigma Black Belt holder and an executive MBA. He is a NABL and NABH assessor and also is a member of various scientific societies (AMBI, ACCLMP, CAHO). He has been awarded the IFCC Roche's Travel Scholarship for Istanbul (2014) and has participated in many various IFCC, APFCB and EFLM programmes, presenting scientific papers in these conferences. He is also the corresponding member of APFCB and IFCC committee.

Qualifications: Dr.Seema Bhargava has an MBBS degree from Government Medical College, Srinagar, J&K (Kashmir University), DNB from Lady Hardinge Medical College, New Delhi, and PhD from Sir Ganga Ram Hospital (SGRH) and Jamia Millia Islamia, New Delhi with a short post-doctoral stint at University of Louisville, Kentucky, USA. Thereafter, she was awarded Fellowships by the Royal College of Pathologists, London (FRCPath) and the Association of Clinical Biochemists of India (FACBI).

Research: She has worked in the Department of Biochemistry at SGRH, New Delhi, since 1992.
Her research on homocysteine has resulted in the implementation of several translational aspects at SGRH in diagnostics and management of vascular disease. Her research continues to focus on identification of clinically relevant biochemical markers and their applications in various areas of medicine like neurology, Alzheimer’s disease, cardiovascular disease, sepsis, immunology, diabetes with special reference to micronutrients deficiency and toxicity, e.g. vitamin B12, lead, etc.

Awards: She is a recipient of several institutional, national and international awards. Most noteworthy are:

• Gold Medal of ‘GRIPMER Best Publication 2012’
• ‘James Willerson Clinical Award’ in 2013
• ‘Dharam Vira Award For Excellence 2014’
• Fellowship of Association of Clinical Biochemists of India, 2018 [FACBI]
• Fellowship of Royal College of Pathologists, London, UK, 2019 [FRCPath]
• IMA NDB Award of Excellence in November, 2021.
• Long Service Awards of 20 years, 25 years and 30 years at Sir Ganga Ram Hospital
• Dr. T. N. Pattabhiraman Oration Award by ACBI.

Publications: She has over 50 publications in national and international indexed journals and several chapters in various books (Biochemistry, Cardiology, National Digital Library). She has also authored a book titled “Clinical Applications of Homocysteine” published by Springer International in 2018.[h-index 14; i10index 21]

Academic: She has guided several PhD and DNB scholars. She is also on the editorial board of IJCB [Indian Journal of Clinical Biochemistry], CMRP [Current Medicine Research and Practice] and JNNSc [Journal of Nature and Natural Sciences] and a reviewer for several other international indexed journals.

Posts held in Societies/Organizations: She has held and still holds executive posts in several national and international academic associations, including ACBI (currently President, previously Vice-President, before that North Zone Executive), IABS, IFCC-EBLM (Member and Visiting Lecturer), InSLAR, ISIEM, ISAR-DC (previously Vice President, Secretary). Currently she is the Chairperson of the Diagnostic Division of CAHO (Consortium of Accredited Healthcare Organizations).
As member of the EBLM Committee of the IFCC, she is involved in various international programmes for the promotion of EBLM and has been invited to several international conferences and Universities to deliver lectures or participate in symposia and workshops.

Quality Assurance: She is a lead assessor and technical assessor for NABL [National Accreditation Board for testing and calibrating Laboratories] and also a member of its Technical as well as Core Committees for Accreditation. She is the Course Director for a one-month course on “Total Laboratory Quality Management and Internal Auditor-ISO 15189:2012” conducted by GRIPMER.

Andreas Bietenbeck is Medical Director of “Labor Poing”, a small medical laboratory close to Munich, Germany. Moreover, he serves as the Chair of the division Medical Informatics of the German Society for Clinical Chemistry and Laboratory Medicine e.V. (DGKL). His research interests include quality control of laboratory tests and especially computationally intensive methods such as patient-based real-time quality control.

Prof Brennecke is the University of Melbourne Dunbar Hooper Professor of Obstetrics and Gynaecology at the Royal Women’s Hospital in Melbourne, Victoria, Australia.

He is also a member of the hospital’s Senior Medical Staff and Head of its Pregnancy Research Centre.

In 2020, he was appointed Officer (AO) of the Order of Australia (General Division) within the Australian Honours system for distinguished service to medical education and research in the field of Obstetrics and Gynaecology, and to professional societies.

Prof Brennecke’s research interests focus on human pregnancy and its complications.

Dr. Jing Cao received her Ph.D. degree in Biochemistry, Molecular Biology and Biophysics from the University of Minnesota, Twin Cities, and is board certified in Clinical Chemistry after completion of fellowship training at the University of Minnesota Medical Center in 2015. She is currently an Associate Professor of Pathology at the University of Texas Southwestern Medical Center (UTSW), Director of mass spectrometry and POCT. She serves on a number of committee positions, including Chair of Association of Diagnostics and Laboratory Medicine (ADLM) Lipoprotein and Vascular Disease Division, Chair of ADLM Texas Section 2023-2025, Past President of North American Chinese Clinical Chemists Association 2019-2020, and Document Development Committee on Newborn Screen for Severe Combined Immunodeficiency in the United States. Dr. Cao leads the United States National Institute of Health-funded translational research studies on blood biomarkers of traumatic brain injury and has over 50 articles on publications including the official journal of ADLM, Clinical Chemistry. She has been invited to present at the ADLM Annual Meeting consecutively for years.

Dr Jenny Cheng is currently a 4th-year Chemical Pathology trainee in Prince of Wales Hospital, Hong Kong SAR. She is a honorary clinical tutor of the Department of Chemical Pathology, the Chinese University of Hong Kong.

A/Prof Chiang is a dually qualified endocrinologist and chemical pathologist. She is the Head of Chemical Pathology at Melbourne Health, the Head of Bone at Austin Health, ANZBMS Councillor and RACP Council Member (Endocrinology and Chemical Pathology representative).

I am a chemical pathologist at Northern Health in Epping, Victoria, Australia. My interests include clinical decision support in laboratory medicine and assisting clinicians in pathology test requesting and result interpretation.

Professor of Clinical Chemistry and Laboratory Medicine
Department of Clinical Chemistry and Laboratory Medicine
Leiden University Medical Centre (LUMC), Leiden, the Netherlands

Professor Cobbaert is a European Specialist in Laboratory Medicine. She is heading the Department of Clinical Chemistry and Laboratory Medicine atthe Leiden University Medical Centre, Leiden, NL since 2009. Her research focuses on Precision Diagnostics with quantitative bottom-up proteomics for accomplishing more sustainable molecular definition of Health and Disease. She currently chairs the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Scientific Division Executive Committee, involved with metrology and standardization of medical tests (http://www.ifcc.org/ifcc-scientific-division/). She is also a member of ISO TC 212 working group 2 on Reference Systems.

In Europe she represents the European Federation in Laboratory Medicine (EFLM) in the IVD subgroup of the Medical Device Coordination Group during meetings with the European Commission on the roll out of the IVDR 2017/746. In this capacity she chairs the EFLM Task Force on European Regulatory Affairs (https://www.eflm.eu/site/page/a/1650).

Her work resulted in ~180 original publications, multiple lectures/webinars and several appointments at (inter)national positions because of her expertise on metrological traceability of test results.

Louise Cullen is a Pre-Eminent Staff Specialist in Emergency Medicine, a clinical trialist and outcomes researcher in acute diseases and biomarkers. She is enthusiastically involved in the translation of research by clinical redesign and innovation.

As an accomplished acute disease researcher, Prof Cullen has focused on the diagnosis and management of patients presenting with possible Acute Coronary Syndromes (ACS) in the Emergency Department (ED). She has been engaged in many international collaborations and has authored over 160 publications in peer-reviewed journals including The New England Journal of Medicine and the Lancet, focussed on strategies to improve efficiency, whilst maintaining safety for patients with possible ACS, syncope, heart failure, shortness of breath and atrial fibrillation.

Professor Cullen’s mantra is that “you do not do research for research’s sake” and as such, clinical redesign and translational research is a key part of her endeavours. She has led widespread implementation of research and established clinical redesign initiatives in Emergency Departments (EDs) across Queensland Health (QH).

Pre-Eminent Staff Specialist, Department of Emergency Medicine
Prof, Queensland University of Technology
Prof, University of Queensland
Royal Brisbane and Women’s Hospital
Brisbane, Queensland 4029, AUSTRALIA.
Tel: (+ 61 7) 3636 7901. Fax: (+ 61 7) 3636 1643.
Email: louise.cullen@health.qld.gov.au
Twitter: @louiseacullen
Qualifications: MBBS (Hon) FACEM FESC PhD

Dr Thyrza Laudamy Darmadi, SpPK graduated he medical degree from Medical Faculty UKRIDA (2004) and did her clinical pathology specialist from University of Indonesia (2013). Presently she is working as a Clinical Pathologist in Pondok Indah – Pondok Indah Hospital. In 2023, she received the IFCC Professional Scientific Exchange Program and learned about the Newborn Screening Program at Children hospital of Eastern Ontario in Ottawa and Sick Kids Hospital in Toronto.

She is active in several organization as:

• Member Of Indonesian Association Of Clinical Pathology & Medical Laboratory (PDS Patklin)
• Member Of Indonesian Association For Clinical Chemistry (IACC) Quality And Laboratory Management Committee
• Member Of Laboratory Hematology Proficiency Test, Indonesian External Quality Assurance Service (INAEQAS)
• Accreditation Assessor For ISO 15189 From National Accreditation Committee (KAN), National Standardization Body
• Member Of Asia Pacific Federation Of Clinical Biochemistry (APFCB) Quality And Laboratory Management Committee
• Member of the Expert Commission of Newborn Screening Program, Indonesian Health Ministry

Dr. Barnali is recipient of three oration awards and seven international and eight national awards from NABH (2023 NABH Best Practices Award of Excellence) College of American Pathologist (CAP Inspector Excellence Honour), American Association of Clinical Chemistry (Outstanding Speaker Award), Univants of Healthcare excellence Global Achievement Award by IFCC, AACC; 2022, International Federation of Clinical Chemistry & Laboratory Medicine (IFCC Development of Quality Competence in Medical Laboratories- DQMCL Award), Asia Pacific Federation of Clinical Biochemistry (Young Scientist Scholarship), Reliance Group Corporate Social Responsibility (The Woman of Substance Award), Seth G.S. Medical College & K.E.M. Hospital Oration Award 2021, Dr. T. N. Pattabhiraman Oration Award, Pitabus Jamuna Burma Memorial Award and Dr. C. Sita Devi Award and Dr. Ajit Singh Saini Oration Award and also Brig. Ramesh Sinha Memorial Certificate & Gold Medal, “Diagnostic Leadership Award in Achiever Category” from Indian Express Group, Zee Business National Healthcare Leadership Award in ‘Woman Leadership Category’. Recently she has received ‘Global Investigator Award’ in LMCE KSLM Laboratory Medicine Congress & Exhibition 2021 & 62nd Annual Meeting, October, 2021. She is recipient of ‘2021 The White Knight Award, Healthcare Heroes of India’ by Metropolis Healthcare and ‘Custodians of Humanity Award 2021’ by IGHM for COVID task force work. She has been honored as “ Best Docs Mumbai 2024, 2023, 2022, 2021 & 2020” in the Laboratory Medicine/ General Pathology field in the magazine ‘Outlook’ and “ Top Doctors Mumbai 2023, 2022, 2021, 2020” in the ‘India Today’. She is collaborating projects with IIT Bombay and other institutes.

She has many research publications in international & national journals (recent one like Clinical Chemistry, European Thyroid Journal, Clinical Biochemistry, Indian Heart Journal, IJCB and IJMB etc.). Her work featured in many news articles in Times of India first page, Hindustan Times, Dainik Jagran, Express Healthcare, CLN News, IFCC enews and cover story of many other magazines. She has delivered more than 100 invited talks & plenary lectures; 3 orations and chaired more than 50 sessions in conferences in different countries. Delivered lectures, short courses and webinars in conferences in US, Europe, Srilanka, Nepal, Saudi Arabia, South Africa, Singapore, Phillipines, Indonesia, Bangladesh and other countries. Her AACC University short course was recognized as “Best of AACC”.

Dr. Xincen Duan is currently a Data Scientist at the Department of Laboratory Medicine of Zhongshan Hospital, Fudan University in Shanghai. He earned his Master of Predictive Analytics (now Data Science) from the DePaul University in Chicago and PhD of Clinical Laboratory Medicine from Shanghai Medical College of Fudan University. His research focus on the application of advance Information technology in clinical laboratories, including patient-based real-time quality control, computer vision in clinical laboratories, and clinical decision support.

Dr. Raja Elina has a degree in Biochemistry and a PhD in Medical Sciences from the University of Malaya. She served several government hospitals until her retirement in 2018. While in service, she setup the Pathology Department at the new Teluk Intan hospital in Perak as well as the Drug and Research Unit in Kuala Lumpur Hospital. She also set up the synthetic drugs of abuses testing, special proteins, therapeutic drug monitoring and tumour markers and was actively involved in quality management activities. She was also the head of the Clinical Biochemist profession, Ministry of Health from 2017-2018.

Dr. Elina is currently the President of the Malaysian Association of Clinical Biochemistry (MACB), Malaysia's representative to the APFCB and the IFCC. She is also the treasurer to the APFCB.

Other international positions she has held include Member of APFCB Laboratory Management Committee (C-LM), Chairman of APFCB Communication and Publications Committee (C-CP), editor of APFCB News, Member of IFCC Reference Intervals and Decision Limits Committee (C-RIDL) and Member of the IFCC Clinical Laboratory Management Committee (C-CLM). Dr. Elina has been invited as a guest speaker at many national and international conferences and in 2017 she was appointed as an APFCB traveling lecturer for a period of 3 years.

Dr. Elina is currently a Senior Technical Assessor under the Department of Standards Malaysia for MS ISO 15189. She is a member of the Technical Committee for Clinical Laboratory Testing & In Vitro Diagnostic Test Systems (TC/R/7) for the Preparation of Malaysian Standards and a member of the international working group for ISO TC 212. In 2020, Dr. Elina was a member of the Malaysian Allied Health Professions Council for the Malaysian Allied Health Professions Act 774 for the term 2020-2023. She is an External Advisor for Sunway University for the Master of Medical Science and Doctor of Philosophy in Medical Science program as well as the Adjunct Professor for the Faculty of Health Sciences, National University of Malaysia.

Chris Farrell is a chemical pathologist with NSW Health Pathology at Liverpool Hospital in Sydney. He has an interest in data science.

Dr. Fernandez-Sesma is currently a professor with tenure and the Chair of the Department of Microbiology at Icahn School of Medicine at Mount Sinai (ISMMS) in New York, NY, USA. Her research focuses on the modulation of innate immunity by viruses of human health interests, such as dengue (DENV), influenza (IAV), human immunodeficiency virus (HIV), Zika (ZIKV), and SARS-CoV-2. Her group uses mainly primary human systems, such as dendritic cells (DCs) and macrophages as well as primary lung epithelial cells and human tonsils for these studies combining molecular and immunological techniques. Her studies aim to understand the mechanisms of immune evasion used by these viruses to establish infection in humans. She currently participates in several multi-investigator projects on DENV, IAV and SARS-CoV-2 that use OMICS technologies to study immune responses to infection and vaccination. She has also participated in several study sections for the National Institutes of Health (NIH/NIAD), the Department of Defense (DoD) and the Centers of Disease Control (CDC) and served in the Scientific Council of the Division of Microbiology and Infectious Diseases (DMID) at NIH/NIAID from 2018-2022. Dr. Fernandez-Sesma chaired the NIAID Human Immunology Project Consortium (HIPC) Steering Committee from 2018-2022. She is strongly committed to graduate education and mentoring. She co-directed the Microbiology Main Training Area of the Graduate School of Biomedical Sciences at ISMMS from 2010 to 2020. She has co-authored numerous publications in Virology and Immunology journals and served on the editorial board of Journal of Virology, mSphere and PLoS Pathogens. Dr. Fernandez-Sesma is a Fellow of the American Academy of Microbiology, a recipient of the Jacobi Medallion from ISMMS and Honorary Alumni of the University of Salamanca, in Spain among other notable recognitions. Dr. Fernandez-Sesma has co-organized the 2023 and 2025 Gordon Research Conference: Viruses and Cells and delivered the Keynote lecture at the 2023 Annual Meeting for the American Society of Virology.

Chris is a consultant in chemical pathology at Canterbury Health Laboratories in Christchurch, New Zealand. He has served for many years on the AACB Working Party on Porphyria and with a particular focus on the Cases for Comment series.

Professor Maria Fuller is a Clinical Scientist specialising in biochemical genetics and leads the National Referral Laboratory within the state-wide public pathology service in South Australia. The laboratory provides a national diagnostic service for lysosomal disorders and has a long-standing interest in improving the efficiency of biochemical diagnosis. Maria has a conjoint academic appointment with the University of Adelaide, where she is a research leader at the Robinson Research Institute, and enjoys supervising post-graduate students as well as hosting clinical placements. She has published over 120 articles in the scientific and medical literature and seven book chapters.

Professor Hague holds one of very few Chairs of Obstetric Medicine in the world, with dual training in both Obstetrics and Internal Medicine in the UK, for many years led the Obstetric Medicine unit at the Women's and Children's Hospital, Adelaide, and is now a clinical trialist, based at the Robinson Research Institute, The University of Adelaide, with a particular focus on metabolic disorders of pregnancy.

He initiated and leads the current international TURRIFIC study in Intrahepatic Cholestasis of Pregnancy (ICP) (funded by MRFF), has led the Metformin in Gestational diabetes (MiG) trial in Australia and its follow-up studies (funded by NHMRC), and was the second lead in the recent TOBOGM study of "early" gestational diabetes (also NHMRC-funded): the recent NEJM paper (Simmons et al) was identified by the ADA as one of 28 "Notable Papers of 2023".

Now more or less retired from clinical practice, Prof Hague maintains an ongoing active research profile, with productive international collaborations in New Zealand, the UK, the Netherlands, Sweden, Finland and Canada. Publications include papers in the New England Journal of Medicine, The Lancet, BMJ, Science, Nature and the Australian Medical Journal. The Founding member and Convenor of the Obstetric Medicine Group of Australasia (now SOMANZ), Prof Hague is a past President of the Australasian Society for the Study of Hypertension in Pregnancy and was previously Meetings organiser for the International Society of Obstetric Medicine.

He chaired the writing group for the SOMANZ Consensus Statement on the diagnosis and management of ICP, recently published on the Society website, and organised and chaired the recent Cholestasis in Pregnancy meeting held alongside the SOMANZ ASM in Adelaide.

Consultant Chemical Pathologist Teaching Hospital Anuradhapura Sri Lanka since November 2014 up to now. During this period I worked as the supervisor of the Renal Research Laboratory, Teaching Hospital Anuradhapura Sri Lanka.

Visiting lecture Rajarata University, Mihinthale. Sri Lanka from 2015 up to now.

President- College of Chemical pathologists Sri Lanka.

Jon Hyett is the Head of the Department of Maternal and Fetal Medicine at Liverpool Hospital, Sydney and the Professor of Obstetrics and Gynaecology at Western Sydney University.

Jon’s primary research interests include predictive modelling and preventative interventions for adverse obstetric outcomes. Many of these models are based on first trimester screening. Others are being developed for managing term pregnancies. He is also interested in management of multiple pregnancies.

Jon is a trustee of the Fetal Medicine Foundation (UK) who have developed a number of risk algorithms used to inform management of pregnancy.

Prof Aamir Ijaz, after graduation from Allama Iqbal Medical College, Lahore (1983), passed MCPS in Clinical Pathology (1988) and FCPS in Chemical Pathology (1995) from Armed Forces Institute of Pathology Rawalpindi, Pakistan. Trained in Paediatric Metabolic Disorders at Great Ormond Street Hospital London, UK. Attended courses on Biorisk Management at Sandia Laboratories, Albuquerque, USA and Patient Safety at Maryland, USA. He has served at UN Hospital in Croatia. He is a qualified medical educationist and done his MCPS-HPE from College of Physisians and Surgeons Pakistan (CPSP). He has nearly 140 publications, authorship of 7 books and book chapters (including “Chemical Pathology for the Beginners) and nearly 110 scientific presentations to his credit. He was founder Chief Editor of PSCP Newsletter ‘The Spectrum’. He remained editor of the Pakistan Journal of Pathology for three years He was awarded FRCP by Royal College of Physicians of Edinburg UK in 2011. He has vast experince of teaching undergraduate medical and science students at various universities. He has trained dozens of postgraduate students of Laboratory Medicine. He is Ex-President of Pakistan Society of Chemical Pathology (full member of APFCB) and Ex-Dean of Faculty of Chemical Pathology at CPSP.

Presently he is the working as Professor of Chemical Pathology at NUST School of Health Sciences, Islamabad Pakistan.

Dr Shivani Jaswal is a MD Biochemist with 20 years’ experience in clinical diagnostics and  research. She is presently working as Professor & Head, Department of Biochemistry at Government Medical College & Hospital, Chandigarh, India. She is the national Coordinator for the Association of Medical Biochemists of India and represented AMBI in the 14th APFCB Congress Taipei (2016) in the APFCB Executive Council. She has also been the corresponding member of various IFCC committees. Apart from Clinical diagnostics, she has also obtained Fellowship in Genetic Diagnostics and has a keen interest in molecular diagnostics.

She has undertaken many research projects and presented papers in national and international conferences.

Anthony A. Killeen, MB, BCh, PhD, MSc, is a Professor of Laboratory Medicine and Pathology and the Director of Clinical Laboratories, at the University of Minnesota Medical Center in Minneapolis, Minnesota. He is the President of the Association for Diagnostics and Laboratory Medicine (formerly AACC).

Dr. Killeen received his medical degree from the National University of Ireland, his M.Sc. from the University of Oxford, and his PhD from the University of Minnesota.

He has served in many leadership positions within ADLM (formerly AACC), including ADLM Secretary from 2017 to 2020. He has been active with external quality assurance programs at the College of American Pathologists, serving in the past as the Chair of the Chemistry,  Instrumentation Resource, and Accuracy-Based Surveys Committees.

Dr. Killeen's research interests are in laboratory quality, clinical trials, hypertension, and the use of "big data" in laboratory medicine.

Dr Leslie Lai is a Consultant in Chemical Pathology & Metabolic Medicine at Gleneagles Hospital Kuala Lumpur where he is also the Laboratory Director. He was Professor of Clinical Biochemistry and Metabolic Medicine as well as Deputy Dean for Academic Affairs at University Putra Malaysia from January 1997 till August 2001 and Dean of the Postgraduate Medical School at the International Medical University in Kuala Lumpur, Malaysia from August 2001 till March 2004. Dr Leslie Lai was Chair of the Asia-Pacific Federation for Clinical Biochemistry and Laboratory Medicine (APFCB) Education Committee from October 1998 till October 2004, Vice President from October 2004 till October 2010, President from October 2010 till December 2016 and Immediate Past President from January 2017 till December 2022. He was a member of the Education and Management Division of the International Federation of Clinical Chemistry and Laboratory Medicine from 2004 till 2008, Vice Chair from 2009 till 2014 and Chair from 2015 till 2020. He was Associate Editor of Clinical Biochemistry from 2008 till 2018 and has been Associate Editor of Malaysian Journal of Pathology since 2008. He also serves on the Editorial Board of the Indian Journal of Clinical Biochemistry, Pathology, The Clinical Biochemist Reviews, Clinical Chemistry and Laboratory Medicine and Practical Laboratory Medicine. He has published widely, particularly in the field of endocrine-related tumours and endocrinology. For his services to the APFCB, Dr Leslie Lai was awarded the APFCB Distinguished Service Award in 2019. His clinical interests are in diabetes, thyroid and adrenal disorders.

MBBS (Melb), DipRCPath, FRCPath, MAACB, DABCC, FADLM, FAMS
Deputy Medical Director & Consultant Pathologist
Parkway Laboratory Services, Singapore

Dr Leslie Lam graduated from The University of Melbourne, Australia and is qualified as a Chemical Pathologist. He is a Fellow of The Royal College of Pathologists (FRCPath), Diplomate of American Board of Clinical Chemistry (DABCC), Fellow of the Association for Diagnostics & Laboratory Medicine Academy (FADLM), Member of Australasian Association of Clinical Biochemists (MAACB) and Fellow of Academy of Medicine, Singapore (FAMS).

Dr Lam was previously the founding Head and Senior Consultant of Department of Laboratory Medicine, Ng Teng Fong General Hospital. Currently, Dr Lam hold multiple portfolios, including President of the Singapore Association of Clinical Biochemists (SACB), Member of Ministry of Health Pathology Specialist Training Committee, Member of Panel of Advisors for Health Sciences Authority External Quality Assessment Program in Clinical Chemistry, etc.

Dr Lam is interested in the areas of laboratory management and quality assurance. He has many years of experience in guiding laboratories to achieving laboratory accreditations, including College of American Pathologists (CAP) and ISO 15189. Dr Lam has been invited to chair and speak at numerous conferences as key opinion leader and has also published widely

Dr Cathie Lane is a clinical nephrologist with over 20 years’ experience managing patients with renal disease and hypertension. She provides nephrology services within Integrated Specialist Medical Care as well as holding a position of staff specialist at St. George Public Hospital.

Dr Lane completed her undergraduate studies at the University of Sydney (BPharm) before pursuing her medical studies at the University of Newcastle. After completing her specialisation as a nephrologist, she pursued a PhD at the University of New South Wales in medical education and has since held positions with the University of New South Wales as an educator.

Her roles within the public hospital system include co-ordination of living related donors for the kidney transplant programme at St. George Hospital in the Eastern Sydney Transplant Network and enjoying participation as a sub-investigator in several clinical trials through the renal research unit.

Within nephrology, apart from her role in renal transplant, her major focus is the control and management of hypertension, kidney stone disease, assessment, management and optimisation of outcomes in patients with reduced renal function.

Sang-Guk Lee, MD, PhD, is a Professor of Laboratory Medicine and a director of clinical chemistry laboratory, at the Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. He is the Director of International Affairs of Korean Society of Clinical Chemistry. His research interests are in clinical metabolomics, clinical mass spectrometry, metabolic disorders and laboratory results standardization.

Coming soon

BSc, MSc, MAACB
Senior Manager, Quality Assurance and Technical Excellence
Parkway Laboratory Services, Singapore

Joanne has worked in both public and private healthcare, accumulating over 20 years of experience leading teams in CAP and ISO 15189 accredited clinical laboratories. Specializing in quality management, quality improvement, scientific and technical affairs, staff training, and laboratory information system, Joanne is well-versed in regulatory requirements and accreditation standards.

Joanne was a key figure of the pioneering team spearheaded the building of the new hospital, Ng Teng Fong General Hospital, situated in western Singapore. Throughout her career, she has assumed numerous leadership positions, including roles as Secretariat for Hospital Point-of-Care Testing Committee, and Member of the Ministry of Health (MOH) Allied Health Panel for Medical Laboratory Technologist. She has published several scientific papers, and speaks regularly at local and international conferences.

Joanne holds a MSc degree from University of Surrey (UK), has MAACB certification, and serves as a Council Member of Singapore Association of Clinical Biochemists (SACB).

Professor Woochang Lee is working for the Department of Laboratory Medicine of Asan Medical Center, University of Ulsan College of Medicine in Seoul, Korea.

He has graduated from Seoul National University College of Medicine and was trained at Asan Medical Center.

He is a board certified clinical pathologist in Korea and specializes in clinical chemistry and molecular genetics.

He has several years’ research experience at University of Texas Southwestern Medical Center in Dallas and University of North Carolina at Chapel Hill.

He is the member of Korean Society for Laboratory Medicine (KSLM), Korean Society of Clinical Chemistry (KSCC), and Korean Society of Genetic Diagnostics (KSGD).

He is now serving as the Director of General Affairs for the Korean Society for Laboratory Medicine (KSLM).

MBBS, FRACP, FRCPA, MAACB

Dr Lim is currently Network Head of Department in Chemical Pathology at PathWest QEII and she oversees the management of Clinical Biochemistry, Pharmacology & Toxicology, Perth Children Hospital and King Edward Memorial Hospital. She is also Acting Director of Regional Support and Services and supervises 22 B-category laboratories. She has an appointment at Sir Charles Gairdner Hospital as Consultant Endocrinologist.

Dr Majid graduated from Dow Medical College (2007) and did her Fellowship in Chemical Pathology (2015) from Aga Khan University. Presently she is working as an Assistant Professor and Director Newborn Screening at the Department of Pathology and Lab Medicine, at Aga Khan University.

Dr Majid is a dedicated professional whose expertise lies in newborn screening, particularly in the diagnostics of Inherited Metabolic Diseases (IMDs) and endocrine metabolic disorders, such as congenital hypothyroidism. With a strong background in research and scholarly activities, Dr. Majid has contributed significantly to the field through more than 60 publications in peer-reviewed journals and active involvement in educational initiatives. By integrating clinical practice and medical education through developing application based educational modules, Dr. Majid strives to equip healthcare professionals with the necessary tools to navigate the complexities of inherited metabolic disorders effectively. Moreover, Dr. Majid has secured grants to support educational endeavours, including developing diagnostic algorithms and curriculum enhancement

Brett McWhinney is the Supervising Chief Scientist of the Analytical Chemistry Unit (ACU) at the Central laboratory (RBWH), Pathology Queensland and is a Founding Fellow Faculty of Science (RCPA).

The ACU is a reference centre for biogenic amine analysis, immunosuppressant monitoring, metabolic screening, steroid analysis and therapeutic drug monitoring. The unit is also responsible for the provision of the newborn screening service for Queensland. He has over 30 years of experience in method development and validation in these areas. He has co-authored over 125 peer reviewed papers and regularly presents lectures on the introduction and application of Mass Spectrometry in a clinical laboratory.

Avis McWhinney is the Supervising Scientist of the Chemical Pathology Specialist Testing Unit at Mater Health, South Brisbane. The testing performed within the Unit includes, diagnosing and monitoring inborn errors of metabolism, Mass Spectrometry analysis of steroids and protein electrophoresis. Avis has been a NATA assessor for over 15 years and is a member of the RCPA QAP Inborn Errors advisory committee.

Dr Prasenjit Mitra is an Assistant Professor (Biochemistry) at the Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh, India.

He is chair of the POCT working group (Asia Pacific Federation of Clinical Biochemistry and Laboratory Medicine (APFCB) Laboratory Management (C-LM) Committee), a member of the International Federation of Clinical Chemistry & Laboratory Medicine (IFCC) Committee on Clinical Laboratory Management (C-CLM), a member of the IFCC Taskforce on Global eLearning (TF-GEL), and a member of the APFCB Laboratory Management Committee. He is a Fellow of the Association for Diagnostics and Laboratory Medicine (FADLM), Association of Clinical Scientists, USA (FACSc), the Linnean Society, UK (FLS), Royal Society for Public Health (FRSPH), Chartered Biologist (CBiol), Chartered Scientist (CSci), European Registered Toxicologist (ERT), member of Royal Society of Biology (MRSB), member of the National Academy of Medical Sciences, India (MAMS) and a member of various International Societies in Clinical Chemistry, Laboratory Medicine, Toxicology, Nutrition, and Medical Education. He is a trained internal auditor (ISO 15189), an international lead assessor (AERSSC), and a certified Lean Six Sigma expert. He has been the recipient of over 25 national and international awards.

He has over 50 publications in peer-reviewed, indexed journals. He is the Section Editor (Pathology) of the European Journal of Medical Research, Associate Editor of the Journal of Biochemical and Molecular Toxicology, Diabetes and Metabolic Syndrome: Clinical Case and Reviews, Indian Journal of Clinical Biochemistry and Human Gene, and Editorial Board member of various journals of international repute. His research interests include extracellular vesicles, molecular psychiatry, metabolic disorders, heavy metal toxicity, and laboratory management.

Samarina Musaad is a Chemical Pathologist with experience in the private community and public sector. She currently works at Waitemata, Labplus and Northland. She is Clinical Director of the Biochemistry Department at LabPlus and oversees POCT in the three hospitals. She is the Clinical Lead for the Northern Region POCT Network and is the IFCC corresponding member for the AACB.

Samarina is passionate about Clinical Leadership and Governance in general and about testing outside-of-the lab specifically, and about clinical utility and risk mitigation of POCT. She also has a keen interest in the role POCT plays in public health and in supporting better access to healthcare delivery.

Keiichi Nakano is a staff clinical laboratory technologist in the department of Laboratory Medicine, Hokkaido University Hospital. He is a member of the Pitfall Research Special Committee of the Japanese Society of Clinical Chemistry (JSCC) and the Scientific and Technical Committee of the Japan Association for Clinical Laboratory Science (JCLS). His main research topic is nonspecific reactions in clinical laboratories, particularly for abnormal proteins. Applying his own research, he responded appropriately to the rare nonspecific reactions that occur in clinical practice.

Professor, Department of Clinical Bioanalysis and Molecular Biology, Institute of Science Tokyo.

Board members of JCLS, JSCC and JCCLS.

Coming soon

Dr Belinda Pope is Chief Operating Officer for Douglass Hanly Moir Pathology. From her early experiences as a research scientist and then her role in the development of a Cord Blood Stem Cell processing and storage laboratory, Belinda has gained valuable insights into quality frameworks, therapeutic goods regulatory requirements and risk mitigation strategies. Belinda was awarded her PhD in the field of Stem Cell processing before becoming Quality and Improvement Manager for Douglass Hanly Moir Pathology. Belinda takes a keen interest in fostering patient centred care through continual quality improvements and development of risk management strategies. Belinda is a committee member of the RCPAQAP KIMMS program.

MD, MPATH, FADUSM, AM(MAL), BCN

Dr. Mohd Jamsani bin Mat Salleh earned his Medical Degree (MD) from Universiti Sains Malaysia (USM) in 2003 and his Master of Pathology (Chemical Pathology) from USM in 2011. He currently serves as the Head of the Chemical Pathology Unit in the Department of Pathology at Hospital Seberang Jaya and as the State Chemical Pathologist in Penang, Malaysia. Additionally, he is a member of the APFCB Lab Management Committee, the MACB Lab Management Sub-Committee, and the Chapter of Chemical Pathology and Metabolic Medicine within the College of Pathologists, Academy of Medicine of Malaysia.

Prof. Praveen Sharma has more than 44 years’ experience of teaching Clinical Biochemistry and Laboratory Medicine. He has over 280 research publications in various prestigious journals and has an interest in Metabolic Syndrome, Atherosclerosis, Antioxidants, Metal Toxicity, and Lab Management. He has delivered Invited Lectures at various National and International Meetings. He has served as Professor and Head of Biochemistry, Dean Research & Controller of Examinations at All India Institute of Medical Sciences, Jodhpur, India. He has also served as Professor of Biochemistry and In-charge Central Lab at SMS Medical College Jaipur and Senior Professor and Head of Biochemistry at Government Medical College Kota.

He is a recipient of Merit award for outstanding services from Govt. of Rajasthan on 26th Jan. 2002 (Award was given for outstanding contribution in improving laboratory investigation services in Rajasthan and creating Central Lab at SMS Hospital Jaipur and its management.

He is a Fellow of the Association of Clinical Biochemists of India (FACBI), Fellow of National Academy of Medical Sciences (FAMS), and Fellow of American Academy of Diagnostic and Laboratory Medicine (FADLM).

He is a recipient of the Presidential oration Award (2004), G S Seth Medical College Oration Award (2004), Pattabiraman Oration Award (2010), Awadhesh saran memorial Oration Awards (2013), and A. J. Thakur-ACBI award (2015) for distinguished service and significant contribution to the field of Clinical Biochemistry. Foundation day oration award 2015, Department of Biochemistry, King George Medical University, Lucknow. Appreciation award 2015 from Indian Society of Lead Awareness and Research (InSLAR) for creating Lead Awareness Amongst School Children.

He has been twice President of ACBI (2003-2004 and 2014-2015) and He is Editor-in-Chief of, Indian Journal of Clinical Biochemistry (IJCB) and Chairman, Corporate Wing of ACBI. Dr. Sharma is the President of the Indian Society for Lead Awareness and Research (InSLAR), Director of the National Referral Center of Lead Project India, Jodhpur and Director, the Foundation for Quality (INDIA) for Rajasthan State, India.

He is a Director, of South East Asia on the World Association of Societies of Pathology and Laboratory Management (WASPaLM) Board from 2020 to date.

Prof. Sharma is the Secretary of, Asia-Pacific Federation for Clinical Biochemistry and Lab Medicine (APFCB). He has also served as Chair Communication Committee of APFCB and Chief Editor of APFCB News from 2010-2019. and Chair of the APFCB Committee on Congress and Conferences 2019-2022. Besides he has also organized the 15th APFCB Congress 2019 from 17th to 20th November 2019 as Organizing Chairman at Jaipur.

He is a Chair of the International Federation of Clinical Chemistry - Committee on Clinical Laboratory Management (IFCC-CCLM) from 2019 to date and also served as a member of the same Committee from 2016-2019.

Honour

AIIMS Jodhpur has established two prestigious awards in honour of Professor Praveen Sharma.

• The first one is the Prof. Praveen Sharma Gold Medal, which is awarded to the MD Biochemistry topper every year.
• The second award is the Prof. Praveen Sharma Oration, which is delivered by eminent and distinguished scientists on AIIMS Jodhpur Research Day annually.

The Association of Clinical Biochemists of India has established the Prof. Praveen Sharma Oration Award, which is presented to outstanding Clinical Biochemists for their exceptional contributions to the field of Clinical Biochemistry. This award is presented every year during the Annual National Conference of ACBI.

Special Distinctions

Recognized as an eminent Indian Biochemists and ranked among top 2% in worldwide scientist from India, for the past three years stated by Stanford University study (Updated science-wide author databases, Plos Biology, 2020,2021 and 2022).

Dean (Faculty of Chemical Pathology - CPSP)

Dr (Prof) Imran Siddiqui is a graduate of Dow Medical College & University from Class of 1989. He started his career at The Aga Khan University Hospital in 1991 and currently attached as full time Professor and Consultant Chemical Pathologist. He is a Fellow of College of Physicians & Surgeons Pakistan; awarded FCPP (Fellowship of College of Pathologist, Pakistan) FRCP-E (Fellow of Royal College of Physicians; Edinburgh) and FRCP-G (Fellow of Royal College of Physicians; Glasgow). He is also the current Dean of Faculties of Chemical Pathology at College of Physician & Surgeons Pakistan. Over the last 3 decades, he has served in leading roles at his Institution & department including Departmental Chair (interim) and Service Line Chief for the largest and the 1st CAP accredited Clinical laboratory of Pakistan. Besides post numerous graduate trainees, Dr Siddiqui has been involved in undergraduate teaching at The Aga Khan Medical School with more than 80 peer reviewed publications, more than hundred national & International abstracts & conference proceeding, author/co-author on three books and multiple grants (Intra & Extramural) under his belt with honorary memberships on editorial board for scientific journals. Dr. Siddiqui was also “Elected President” for Pakistan Society of Chemical Pathologist (2011-2013) in Pakistan, represented Pakistan at IFCC (Indonesia in 2013 & Spain March 2016).

Professor& Head
Department of Biochemistry
Nalanda Medical College

Dr. Pavai Sthaneshwar graduated from Kilpauk Medical College, India. She is currently holding the position of Associate Professor in the Department of Pathology, University Malaya. She is the academic person in-charge for Chemical Pathology in the Division of Laboratory Medicine. Her interests are improvement of the services provided by the clinical laboratories. She is currently a member of the Malaysian Association of Clinical Biochemistry and Chapter of Chemical Pathology and Metabolic Medicine, College of Pathologists, Academy of Medicine of Malaysia (CPMM, CPath AMM) scientific committee.

C. Swart studied Chemistry at the University of Regensburg with focus on analytical chemistry. She received her PhD from the Free University in Berlin in the field of archaeometry. After her PhD, she worked at the Bundesanstalt für Materialforschung und -prüfung (BAM) in the field of speciation analysis analysing arsenic species in water and biota. 2008 she moved on to the Physikalisch-Technische Bundesanstalt (PTB) in Braunschweig, which is the National Metrology Institute of Germany, where she is currently leading the working group “Speciation Analysis”. Her focus is on the development of reference measurement procedures for metalloproteins and metabolites in clinical samples. Furthermore, she chairs the working group on troponin I (WG-TNI) within the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) and the Protein Analysis Working Group within the Consultative Committee for Amount of Substance: Metrology in Chemistry and Biology (CCQM). She is also a member of the review team for proteins within the Joint Committee for Traceability in Laboratory Medicine (JCTLM) and a member of the Sub Committee Bio and Organic Analysis of the Technical Committee for Metrology in Chemistry within EURAMET.

Dr Jun Guan Tan is a Chemical Pathologist at Khoo Teck Puat Hospital, Singapore.  He obtained his FRCPA and FAACB in 2021.

Senior Lecturer, Swinburne University, Melbourne
Researcher/Educator, Victorian Clinical Genetic Services

Mercy Thomas is a highly accomplished registered nurse with a distinguished career in clinical practice, project management, quality improvement and education. Her diverse experience spans acute, sub-acute, and educational settings, offering a well-rounded perspective on healthcare delivery. Mercy’s doctoral research focused on optimising neonatal jaundice screening practices in Victorian community settings. She actively translates her research findings into real world impact by publishing academic studies, collaborating with clinicians and decision makers, and advocating for evidence-based practices in providing newborn care.

Dr Mai Tran has been working in clinical biochemistry for 15 years. She is also working in Hanoi Medical University as Biochemistry lecturer. Her main research interests focus on laboratory management, special laboratory techniques used for screening, diagnosing and monitoring the inborn errors of metabolism. She has published more than 70 papers on domestic and international journals.

MBBS, Post Graduate Diploma in Chemical Pathology, MD in Chemical Pathology, Board Certified Consultant Chemical Pathologist and the Head of the Department of Pathology, Teaching Hospital Badulla, Sri Lanka.

Post MD overseas training at Liverpool and Royal Prince Alfred Hospitals, New South Wales, Australia.

Lecturer in Chemical Pathology at Post Graduate Institute of Medicine, Sri Lanka.

Visiting lecturer at faculty of Medicine, University of Uva Wellassa, Sri Lanka.

Reviewer BMJ Case Reports.

Co – editor of the College of Chemical Pathologist of Sri Lanka in 2022 and 2023.

Principal supervisor of many research conducted by the students following Medical Laboratory Science degree.

Research interests are in the field of Oncology and Endocrinology.

Dr Nilika Wijeratne is a Chemical Pathologist at Eastern Health Pathology, Victoria, Australia. She is also an Adjunct Lecturer in the Department of Medicine, Monash University.

Dr Wijeratne is a member of the RCPAQAP Advisory Committee on Patient Report Comments and Multidisciplinary Working Party on Monoclonal Gammopathy. She is a RCPA- Chemical Pathology Examiner and NATA assessor.

MBBS, Post Graduate Diploma in Chemical Pathology, MD in Chemical Pathology

Board certified consultant in Chemical Pathology

Post MD overseas training as an honorary fellow at Fiona Stanly Hospital, Perth, Australia

Joint secretary of the College of Chemical Pathologist of Sri Lanka (CCPSL) in 2019 -2020 and 2020 – 2021

Co – editor of the College of Chemical Pathologist of Sri Lanka (CCPSL) in 2022 - 2023

Technical assessor in Sri Lanka Accreditation Board

Secretary of Ruhunu Clinical Society in 2019 – 2020 and 2023 - 2024

Examiner in screening examination leading to MD part I in Pathology, CBLS and MD Chemical pathology

Visiting lecturer in Post Graduate Institute of Medicine, Sri Lanka

Dr Felix Wong is currently a Consultant Chemical Pathologist in Queen Mary Hospital, Hong Kong SAR, China. He obtained his RCPA Fellowship in 2019 and Fellowship of The Hong Kong College of Pathologists (HKCPath) in 2020. He obtained his postgraduate HKCPath Genetics and Genomics Fellowship in 2022. He is practicing in the teaching hospital of The University of Hong Kong (HKU) and is a Clinical Associate Professor (honorary) of HKU.

Dr Rosita Zakaria is a Medical Scientist and Lecturer in the Discipline of Laboratory Medicine at RMIT University. She is currently the program manager of the Laboratory Medicine undergraduate degrees at RMIT and, serves as Education Representative and Committee Member of AACB Victoria Branch, Member of the IFCC Working Group on Method Evaluation Protocols, and an Honorary Research position holder at MCRI.

Zhen Zhao is a Professor of Clinical Pathology and Laboratory Medicine at Weill Cornell Medicine. She is the Director of Central Laboratory and Clinical Chemistry Service at the New York-Presbyterian Weill Cornell Medical Centre. She received her BS in biology from Xiamen University and PhD from Northwestern University. She fulfilled clinical chemistry postdoctoral fellowship training at Washington University in St. Louis. She is board certified by the American Board of Clinical Chemistry. Prior to joining the faculty at Weill Cornell, she served as the Director of General Chemistry and Immunoassay and the Associated Director of the clinical chemistry fellowship postdoctoral training program in the Department of Laboratory Medicine of the National Institutes of Health. She has written 4 book chapters, given over 40 invited lectures/symposia locally, nationally, and internationally and published over 90 peer reviewed papers. She serves/served on several committees including Chair of IFCC Task Force on Outcome Studies in Laboratory Medicine (TF-OSLM), Member of ADLM Academy Council, Chair of ADLM Academy Scientific Shorts, Co-Chair of AACC COVID-19 Community Study and President of the North American Chinese Clinical Chemists Association (NACCCA). She has received several awards including NIH Clinical Centre Director’s Award, AACC Capital Local Section Roe Award, NACB’s Distinguished Abstract Award, AACC Endocrinology Division Outstanding Abstract Award and NACCCA Outstanding Research Award.